Get started
RocketTickers

Junshi Biosciences and Coherus Announce Positive Interim Overall

Long
Coherus BioSciences, Inc. (NASDAQ:CHRS)  
RocketTickers  
NASDAQ:CHRS   Coherus BioSciences, Inc.
Beyond Technical Analysis
0
0
beyondta
CHRS: Junshi Biosciences
2021-12-13 07:00:00
Junshi Biosciences and Coherus Announce Positive Interim Overall Survival Results of CHOICE-01, a Phase 3 Clinical Trial Evaluating Toripalimab in Combination with Chemotherapy as First-Line Treatment for Non-Small Cell Lung Cancer
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.